Arsenic or/and antimony induced mitophagy and apoptosis associated with metabolic abnormalities and oxidative stress in the liver of mice

Gaolong Zhong,Fang Wan,Shaofeng Wu,Xuanxuan Jiang,Zhaoxin Tang,Xiaoyong Zhang,Riming Huang,Lianmei Hu

DOI: https://doi.org/10.1016/j.scitotenv.2021.146082

2021-07-01

Abstract:<p>Arsenic and antimony are coexisting cumulative environmental pollutants that cause severe and extensive biological toxicity. However, their interactions and toxic mechanisms in the liver remain to be fully elucidated. In this study, a total of sixty 4-week-old mice were divided into four groups and treated with 4 mg/kg arsenic trioxide (ATO) or/and 15 mg/kg antimony (Sb) for 60 days. The results demonstrated that biochemical indicators of hepatotoxicity (ALT, AST, ALP) were upregulated in all treated groups. Additionally, the oxidative burden of the liver was increased in the cotreated groups compared with the individual toxicant-treated groups. Meanwhile, mitochondrial injury, autophagosomes, hepatic-congestion and karyopyknosis were obviously observed in cotreated groups. Additionally, coupled with serum biochemical index (TG, TC), histopathology examination and metabolomics results, we found that cotreatment with ATO and Sb resulted in lipid metabolism disorder and steatosis of liver tissues. Our further investigation found that the levels of pro-apoptotic (Caspase-3, Caspase-9, Bax, P53, Cytc) and mitophagy (LC3-B, P62, PINK1, Parkin) indexes in the cotreated groups were markedly increased, whereas the levels of anti-apoptosis index (Bcl-2) were decreased. Collectively, these results show that co-exposure to ATO and Sb can cause abnormal liver energy metabolism and oxidative stress. Moreover, mitophagy and apoptosis play important roles in the mechanisms of arsenic/antimony cytotoxicity to mouse livers.</p>

environmental sciences

What problem does this paper attempt to address?

The paper aims to explore the effects of co-exposure to arsenic trioxide (ATO) and antimony (Sb) on metabolic abnormalities, oxidative stress, and mitochondria-related biological processes (including apoptosis and autophagy) in the liver of mice, and to reveal the potential toxic mechanisms. Specifically, the study found: 1. **Liver coefficient and biochemical indicators**: ATO or Sb treatment alone, as well as their co-treatment, significantly increased the liver coefficient (the ratio of liver weight to body weight) in mice. The levels of ALT, AST, and ALP in serum were also significantly elevated, indicating liver damage. 2. **Arsenic and antimony content**: The content of arsenic and antimony in liver tissues was significantly increased, especially in the ATO and Sb co-treatment group. 3. **Histopathological observations**: Histopathological changes in liver tissues showed that ATO or Sb treatment led to varying degrees of liver damage, manifested as sinusoidal congestion, irregular nuclei, and chromatin marginalization. These effects were more pronounced in the ATO and Sb co-treatment group. 4. **Oxidative damage parameters**: ATO or Sb treatment significantly increased the total antioxidant capacity (T-AOC) and malondialdehyde (MDA) levels in liver tissues, and the activity of superoxide dismutase (SOD) was also significantly elevated. 5. **Mitophagy**: ATO or Sb treatment significantly upregulated the expression of genes related to mitophagy, such as LC3-B, Parkin, and PINK1, while the expression of P62 was significantly decreased. 6. **Apoptosis**: ATO or Sb treatment significantly upregulated the expression of genes related to apoptosis, such as Caspase-3, Caspase-9, Bax, P53, and Cytc, while the expression of the anti-apoptotic gene Bcl-2 was significantly decreased. 7. **Metabolomics analysis**: Co-treatment with ATO and Sb significantly altered the levels of metabolites in the liver of mice, especially the glycerophospholipid metabolism and linoleic acid metabolism pathways. In summary, the study revealed the mechanisms of liver damage caused by co-exposure to ATO and Sb in mice, including the synergistic effects of oxidative stress, mitophagy, and apoptosis.

Arsenic or/and antimony induced mitophagy and apoptosis associated with metabolic abnormalities and oxidative stress in the liver of mice

Disruption of mitochondrial redox homeostasis as a mechanism of antimony-induced reactive oxygen species and cytotoxicity

Mechanisms of Arsenic Trioxide Induced Tumor Cell Apoptosis in Myelodysplastic Syndrome Mice Model in Vivo

Arsenic and antimony co-induced nephrotoxicity via autophagy and pyroptosis through ROS-mediated pathway in vivo and in vitro

Arsenic exposure at environmentally relevant levels induced metabolic toxicity in development mice: Mechanistic insights from integrated transcriptome and metabolome

Combined effect of arsenic and polystyrene-nanoplastics at environmentally relevant concentrations in mice liver: Activation of apoptosis, pyroptosis and excessive autophagy

Integrated metabolomics and network pharmacology revealing the mechanism of arsenic-induced hepatotoxicity in mice

Arsenic (III) and/or Antimony (III) induced disruption of calcium homeostasis and endoplasmic reticulum stress resulting in apoptosis in mice heart

Gut microbiota deficiency aggravates arsenic-induced toxicity by affecting bioaccumulation and biotransformation in C57BL/6J mice

Arsenic-Induced Injury of Mouse Hepatocytes through Lysosome and Mitochondria: An In Vitro Study

Arsenic Trioxide Or/and Copper Sulfate Co-Exposure Induce Glandular Stomach of Chicken Injury Via Destruction of the Mitochondrial Dynamics and Activation of Apoptosis As Well As Autophagy.

Arsenic Trioxide And/or Copper Sulfate Induced Apoptosis and Autophagy Associated with Oxidative Stress and Perturbation of Mitochondrial Dynamics in the Thymus of Gallus Gallus

Destruction of redox and mitochondrial dynamics co-contributes to programmed cell death in chicken kidney under arsenite or/and copper (II) exposure

Effects of dietary arsenic exposure on liver metabolism in mice

Alterations of Antioxidant Indexes and Inflammatory Cytokine Expression Aggravated Hepatocellular Apoptosis Through Mitochondrial and Death Receptor-Dependent Pathways in Gallus Gallus Exposed to Arsenic and Copper.

Oxidative damage under As 3+ and/or Cu 2+ stress leads to apoptosis and autophagy and may be cross-talking with mitochondrial disorders in bursa of Fabricius.

Intestinal microbiota dysbiosis contributes to the liver damage in subchronic arsenic-exposed mice

Arsenic-Induced Ferroptosis in Chicken Hepatocytes via the Mitochondrial ROS Pathway

Long-term arsenic exposure decreases mice body weight and liver lipid droplets

The gut microbiome promotes arsenic metabolism and alleviates the metabolic disorder for their mammal host under arsenic exposure

Attenuation of chromium (VI) and arsenic (III)-induced oxidative stress and hepatic apoptosis by phloretin, biochanin-A, and coenzyme Q10 via activation of SIRT1/Nrf2/HO-1/NQO1 signaling